Back Bay Life Science Report
by Jonathan P. Gertler and Peter Bak
February 8, 2025 4:15 am
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.
Recent Episodes
A Capital Markets Outlook for 2025: 2024, A Year in Review
5 months agoThe Optimism of Bispecific Antibodies
8 months agoDynamics in Healthcare Focused Markets
10 months agoFrom NASH to MASH: Current Market Dynamics in Hepatology
10 months agoKey Considerations for a US Healthcare IPO
1 year agoDrug Development in Obesity
1 year agoThe Current Dynamics in Capital Markets
1 year agoVaccine Developments 2024: A Podcast Discussion on Latest Vaccine Technology and Ongoing Clinical Developments
1 year agoTrends and Investment Activity in Radiopharmaceuticals and Psychedelics
1 year agoVertex’s Exa-cel to Biogen and Sage’s Zurzuvae: Notable Product Approvals of 2023
2 years ago